GATA3 in development and cancer differentiation: Cells GATA have it!

Journal of Cellular Physiology

Volumn 222, Issue 1, 2010, Pages 42-49

  Chou, Jonathan ^a,b   Provot, Sylvain ^a   Werb, Zena ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 3;

ADIPOCYTE; ALLERGIC DISEASE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; DISEASE COURSE; DNA FLANKING REGION; DRUG POTENCY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MAPPING; GENE TARGETING; HUMAN; IMMUNE SYSTEM; MAMMARY GLAND; MICROARRAY ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; SHORT SURVEY; SKIN; T LYMPHOCYTE; TUMOR LOCALIZATION;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; EMBRYONIC DEVELOPMENT; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; NEOPLASM METASTASIS; ORGAN SPECIFICITY;

EID: 73949087506     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21943     Document Type: Short Survey

References (88)

1. Abba MC, Nunez MI, Colussi AG, Croce MV, Segal-Eiras A, Aldaz CM. 2006. GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells. Breast Cancer Res 8:R64.
2. Amsen D, Antov A, Jankovic D, Sher A, Radtke F, Souabni A, Busslinger M, McCright B, Gridley T, Flavell RA. 2007. Direct regulation ofGata3 expression determines the T helper differentiation potential of Notch. Immunity 27:89-99.
3. Ansel KM, Djuretic I, Tanasa B, Rao A. 2006. Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24:607-656.
4. Asselin-Labat ML, Sutherland KD, BarkerH, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE. 2007. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9:201-209.
5. Avni O, Lee D, Macian F, Szabo SJ, Glimcher LH, Rao A. 2002. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol 3:643-651.
6. Bates DL, Chen Y, Kim G, Guo L, Chen L. 2008. Crystal structures of multiple GATA zinc fingers bound to DNA reveal new insights into DNA recognition and self-association by GATA. J Mol Biol 381:1292-1306.
7. Bingle L, Brown NJ, Lewis CE. 2002. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 196:254-265.
8. Blokzijl A, ten Dijke P, Ibanez CF. 2002. Physical and functional interaction between GATA-3 and Smad3 allows TGF-beta regulation of GATA target genes. Curr Biol 12:35-45.
9. Chang HC, Zhang S, Thieu VT, Slee RB, Bruns HA, Laribee RN, Klemsz MJ, Kaplan MH. 2005. PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 22:693-703.
10. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860-867.
11. de Guzman Strong C, Wertz PW, Wang C, Yang F, Meltzer PS, Andl T, Millar SE, Ho IC, Pai SY, Segre JA. 2006. Lipid defect underlies selective skin barrier impairment of an epidermalspecific deletion of Gata-3. J Cell Biol 175:661-670.
12. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, Coussens LM. 2009. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16:91-102.
13. Dolled-Filhart M, Ryden L, Cregger M, Jirstrom K, Harigopal M, Camp RL, Rimm DL. 2006. Classification of breast cancer using genetic algorithms and tissuemicroarrays. Clin Cancer Res 12:6459-6468.
14. Dore LC, Amigo JD, Dos Santos CO, Zhang Z, Gai X, Tobias JW, Yu D, Klein AM, Dorman C, Wu W, Hardison RC, Paw BH, Weiss MJ. 2008. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA 105:3333-3338.
15. Dydensborg AB, Rose AA, Wilson BJ, GroteD, Paquet M, Giguere V, Siegel PM, Bouchard M. 2009. GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene 28:2634-2642.
16. Fang TC, Yashiro-Ohtani Y, Del Bianco C, Knoblock DM, Blacklow SC, Pear WS. 2007. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27:100-110.
17. Fuchs E. 2007. Scratching the surface of skin development. Nature 445:834-842.
18. Goldfarb DS, Corbett AH, Mason DA, Harreman MT, Adam SA. 2004. Importin alpha: A multipurpose nuclear-transport receptor. Trends Cell Biol 14:505-514.
19. Grogan JL, Locksley RM. 2002. T helper cell differentiation: On again, off again. Curr Opin Immunol 14:366-372.
20. Gregory BD, O'Malley RC, Lister R, Urich MA, Tonti-Filippini J, Chen H, Millar AH, Ecker JR. 2008. A link between RNA metabolism and silencing affecting Arabidopsis development. Dev Cell 14:854-866.
21. GroteD, Boualia SK, Souabni A, Merkel C, Chi X, Costantini F, Carroll T, Bouchard M. 2008. Gata3 acts downstream of beta-catenin signaling to prevent ectopic metanephric kidney induction. PLoS Genet 4:e1000316.
22. Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K, Gerald WL, Brogi E, Benezra R, Massague J. 2007. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA 104:19506-19511.
23. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES. 2009. Identification of selective inhibitors of cancer stem cells by high-throughput screening.Cell 138:1-15.
24. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
25. Ho IC, Pai SY. 2007. GATA-3 - not just for Th2 cells anymore. Cell Mol Immunol 4:15-29.
26. Ho IC, Tai TS, Pai SY. 2009. GATA3 and the T-cell lineage: Essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol 9:125-135.
27. Hoch RV, Thompson DA, Baker RJ, Weigel RJ. 1999. GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 84:122-128.
28. Hong SJ, Choi HJ, Hong S, Huh Y, Chae H, Kim KS. 2008. Transcription factor GATA-3 regulates the transcriptional activity of dopamine beta-hydroxylase by interacting with Sp1 and AP4. Neurochem Res 33:1821-1831.
29. Ibarra I, Erlich Y, Muthuswamy SK, Sachidanandam R, Hannon GJ. 2007. A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev 21:3238-3243.
30. Jenssen TK, Kuo WP, Stokke T, Hovig E. 2002. Associations between gene expressions in breast cancer and patient survival. Hum Genet 111:411-420.
31. Jones JM, Warchol ME. 2009. Expression of the Gata3 transcription factor in the acoustic ganglion of the developing avian inner ear. J Comp Neurol 516:507-518.
32. Kaufman CK, Zhou P, Pasolli HA, Rendl M, Bolotin D, Lim KC, Dai X, Alegre ML, Fuchs E. 2003. GATA-3: An unexpected regulator of cell lineage determination in skin. Genes Dev 17:2108-2122.
33. Kouros-Mehr H, Werb Z. 2006. Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn 235:3404-3412.
34. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. 2006. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127:1041-1055.
35. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z. 2008. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13:141-152.
36. Kufe DW, Bast RC. 2003. Cancer medicine. Hamilton, Ont, London: BC Decker. 2 v. (xxiv, 2699,2640 p.) p.
37. Kurek D, Garinis GA, van Doorninck JH, van der Wees J, Grosveld FG. 2007. Transcriptome and phenotypic analysis reveals Gata3-dependent signalling pathways in murine hair follicles. Development 134:261-272.
38. Lee GR, Fields PE, Flavell RA. 2001. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14:447-459.
39. Lim KC, Lakshmanan G, Crawford SE, Gu Y, Grosveld F, Engel JD. 2000. Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat Genet 25:209-212.
40. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ. 2009. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15:907-913.
41. Lin EY, Nguyen AV, Russell RG, Pollard JW. 2001. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727-740.
42. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW. 2003. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 163:2113-2126.
43. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW. 2006. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66:11238-11246.
44. Lu P, Werb Z. 2008. Patterning mechanisms of branched organs. Science 322:1506-1509.
45. Ma L, Teruya-Feldstein J, Weinberg RA. 2007. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682-688.
46. Ma L, Weinberg RA. 2008. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet 24:448-456.
47. Maeda A, Moriguchi T, Hamada M, Kusakabe M, Fujioka Y, Nakano T, Yoh K, Lim KC, Engel JD, Takahashi S. 2009. Transcription factor GATA-3 is essential for lens development. Dev Dyn 238:2280-2291.
48. Maneechotesuwan K, Xin Y, Ito K, Jazrawi E, Lee KY, Usmani OS, Barnes PJ, Adcock IM. 2007. Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol 178:2491-2498.
49. Maneechotesuwan K, Yao X, Ito K, Jazrawi E, Usmani OS, Adcock IM, Barnes PJ. 2009. Suppression of GATA-3 nuclear import and phosphorylation: A novel mechanism of corticosteroid action in allergic disease. PLoS Med 6:e1000076.
50. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
51. Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG. 2005. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res 65:11259-11264.
52. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. 2005. Genes that mediate breast cancer metastasis to lung. Nature 436:518-524.
53. Moriguchi T, Takako N, Hamada M, Maeda A, Fujioka Y, Kuroha T, Huber RE, Hasegawa SL, Rao A, Yamamoto M, Takahashi S, Lim KC, Engel JD. 2006. Gata3 participates in a complex transcriptional feedback network to regulate sympathoadrenal differentiation. Development 133:3871-3881.
54. Nesbit MA, Bowl MR, Harding B, Ali A, Ayala A, Crowe C, Dobbie A, Hampson G, Holdaway I, Levine MA, McWilliams R, Rigden S, Sampson J, Williams AJ, Thakker RV. 2004. Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem 279:22624-22634.
55. Nguyen DX, Bos PD, Massague J. 2009. Metastasis: From dissemination to organ-specific colonization. Nat Rev Cancer 9:274-284.
56. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9:745-755.
57. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, Engel JD, Lindenbaum MH. 1995. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 11:40-44.
58. Pase L, Layton JE, Kloosterman WP, Carradice D, Waterhouse PM, Lieschke GJ. 2009. miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood 113:1794-1804.
59. Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai SY, Ho IC, Perou CM, Xiong Y. 2009. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell 15:389-401.
60. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. 2000. Molecular portraits of human breast tumours. Nature 406:747-752.
61. Pollard JW. 2009. Trophic macrophages in development and disease. Nat Rev Immunol 9:259-270.
62. Ranganath S, Murphy KM. 2001. Structure and specificity of GATA proteins in Th2 development. Mol Cell Biol 21:2716-2725.
63. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. 2006. Generation of a functional mammary gland from a single stem cell. Nature 439:84-88.
64. Smalley M, Ashworth A. 2003. Stem cells and breast cancer: A field in transit. Nat Rev Cancer 3:832-844.
65. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874.
66. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423.
67. Sternlicht MD, Kouros-Mehr H, Lu P, Werb Z. 2006. Hormonal and local control of mammary branching morphogenesis. Differentiation 74:365-381.
68. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. 2006. Purification and unique properties of mammary epithelial stem cells. Nature 439:993-997.
69. Taghon T, Yui MA, Rothenberg EV. 2007. Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nat Immunol 8:845-855.
70. Takahashi S, Shimizu R, Suwabe N, Kuroha T, Yoh K, Ohta J, Nishimura S, Lim KC, Engel JD, Yamamoto M. 2000. GATA factor transgenes under GATA-1 locus control rescue germline GATA-1 mutant deficiencies. Blood 96:910-916.
71. Takemoto N, Arai K, Miyatake S. 2002. Cutting edge: The differential involvement of the N-finger of GATA-3 in chromatin remodeling and transactivation during Th2 development. J Immunol 169:4103-4107.
72. Takeuchi JK, Bruneau BG. 2009. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 459:708-711.
73. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J. 2008. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147-152.
74. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS. 2000. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290:134-138.
75. Tsai FY, Browne CP, Orkin SH. 1998. Knock-in mutation of transcription factor GATA-3 into the GATA-1 locus: Partial rescue of GATA-1 loss of function in erythroid cells. Dev Biol 196:218-227.
76. Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerod A, Karesen R, Oh DS, Dressler LG, Lonning PE, Strausberg RL, Chanock S, Borresen-Dale AL, Perou CM. 2004. Mutation of GATA3 in human breast tumors. Oncogene 23:7669-7678.
77. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA. 2009. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137:1032-1046.
78. Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K. 2000. GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406:419-422.
79. van Hamburg JP, de Bruijn MJ, Dingjan GM, Beverloo HB, Diepstraten H, Ling KW, Hendriks RW. 2008. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes. Mol Immunol 45:3085-3095.
80. Visvader JE, Lindeman GJ. 2008. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 8:755-768.
81. Voduc D, Cheang M, Nielsen T. 2008. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomarkers Prev 17:365-373.
82. Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugaya K, Hosokawa H, Hasegawa A, Kimura M, Taniguchi M, DeGregori J, Nakayama T. 2004. Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J Biol Chem 279:26983-26990.
83. Yamashita M, Shinnakasu R, Asou H, Kimura M, Hasegawa A, Hashimoto K, Hatano N, Ogata M, Nakayama T. 2005. Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway. J Biol Chem 280:29409-29419.
84. Yang J, Weinberg RA. 2008. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 14:818-829.
85. Yang Z, Gu L, Romeo PH, Bories D, Motohashi H, Yamamoto M, Engel JD. 1994. Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains. Mol Cell Biol 14:2201-2212.
86. Zhao GY, Li ZY, Zou HL, Hu ZL, Song NN, Zheng MH, Su CJ, Ding YQ. 2008. Expression of the transcription factor GATA3 in the postnatal mouse central nervous system. Neurosci Res 61:420-428.
87. Zhou M, Ouyang W. 2003. The function role of GATA-3 in Th1 and Th2 differentiation. Immunol Res 28:25-37.
88. Zhou M, Ouyang W, Gong Q, Katz SG, White JM, Orkin SH, Murphy KM. 2001. Friend of GATA-1 represses GATA-3-dependent activity in CD4+ T cells. J Exp Med 194:1461-1471.